Lymphatic mapping in the molecular era

Same author

Years of life lost in patients with a false-negative diagnosis of primary melanoma. A prospective study of the German Central Malignant Melanoma Registry involving 9063 patients over 28 years.

Nature communications·2026

Same author

Melanoma-patient-derived xenograft multi-omics resource melPDomiX maps gain- and loss-of-function alterations.

Cell reports·2026

Same author

Germline variants in cancer susceptibility genes among patients with mucosal melanoma.

NPJ genomic medicine·2026

Same author

Correction: Real-World Outcomes for Patients with Clinically Node-Positive Melanoma Undergoing Neoadjuvant Immunotherapy and Nodal Dissection.

Annals of surgical oncology·2026

Same author

The global cancer crisis: a review of growing burden, deepening inequality and initiatives for prevention and early detection.

Ecancermedicalscience·2026

Same author

Real-World Outcomes for Patients with Clinically Node-Positive Melanoma Undergoing Neoadjuvant Immunotherapy and Nodal Dissection.

Annals of surgical oncology·2026

Same journal

Impact of R0/R1 Margin Status on Overall Survival in Node-Positive Resected Pancreatic Ductal Adenocarcinoma: Meta-Analysis.

Annals of surgical oncology·2026

Same journal

ASO Author Reflections: Can Immunochemotherapy Redefine Neoadjuvant Treatment for Node-Positive Esophageal Squamous Cell Carcinoma?

Annals of surgical oncology·2026

Same journal

ASO Visual Abstract: High-Volume Anesthesiologist and Surgeon Teams are Associated with Lower Operating Room Charges for Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.

Annals of surgical oncology·2026

Same journal

Lymphovascular Invasion in SOUND-Eligible Breast Cancer: Implications for Occult Axillary Nodal Metastasis.

Annals of surgical oncology·2026

Same journal

Taking Leave During Breast Surgical Oncology Fellowship: A National Evaluation of Policy and Practice.

Annals of surgical oncology·2026

Same journal

The Dual Face of PD-L1 in Perioperative EGFR-Mutated Lung Cancer-Promise, Paradox, and the Path Forward.

Annals of surgical oncology·2026

Related Experiment Videos

Lymphatic mapping in the molecular era

Related Concept Videos

Years of life lost in patients with a false-negative diagnosis of primary melanoma. A prospective study of the German Central Malignant Melanoma Registry involving 9063 patients over 28 years.

Melanoma-patient-derived xenograft multi-omics resource melPDomiX maps gain- and loss-of-function alterations.

Germline variants in cancer susceptibility genes among patients with mucosal melanoma.

Correction: Real-World Outcomes for Patients with Clinically Node-Positive Melanoma Undergoing Neoadjuvant Immunotherapy and Nodal Dissection.

The global cancer crisis: a review of growing burden, deepening inequality and initiatives for prevention and early detection.

Real-World Outcomes for Patients with Clinically Node-Positive Melanoma Undergoing Neoadjuvant Immunotherapy and Nodal Dissection.

Impact of R0/R1 Margin Status on Overall Survival in Node-Positive Resected Pancreatic Ductal Adenocarcinoma: Meta-Analysis.

ASO Author Reflections: Can Immunochemotherapy Redefine Neoadjuvant Treatment for Node-Positive Esophageal Squamous Cell Carcinoma?

ASO Visual Abstract: High-Volume Anesthesiologist and Surgeon Teams are Associated with Lower Operating Room Charges for Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.

Lymphovascular Invasion in SOUND-Eligible Breast Cancer: Implications for Occult Axillary Nodal Metastasis.

Taking Leave During Breast Surgical Oncology Fellowship: A National Evaluation of Policy and Practice.

The Dual Face of PD-L1 in Perioperative EGFR-Mutated Lung Cancer-Promise, Paradox, and the Path Forward.

Related Experiment Videos

Lymphatic mapping in the molecular era

Related Concept Videos

Related Articles

Years of life lost in patients with a false-negative diagnosis of primary melanoma. A prospective study of the German Central Malignant Melanoma Registry involving 9063 patients over 28 years.

Melanoma-patient-derived xenograft multi-omics resource melPDomiX maps gain- and loss-of-function alterations.

Germline variants in cancer susceptibility genes among patients with mucosal melanoma.

Correction: Real-World Outcomes for Patients with Clinically Node-Positive Melanoma Undergoing Neoadjuvant Immunotherapy and Nodal Dissection.

The global cancer crisis: a review of growing burden, deepening inequality and initiatives for prevention and early detection.

Real-World Outcomes for Patients with Clinically Node-Positive Melanoma Undergoing Neoadjuvant Immunotherapy and Nodal Dissection.

Impact of R0/R1 Margin Status on Overall Survival in Node-Positive Resected Pancreatic Ductal Adenocarcinoma: Meta-Analysis.

ASO Author Reflections: Can Immunochemotherapy Redefine Neoadjuvant Treatment for Node-Positive Esophageal Squamous Cell Carcinoma?

ASO Visual Abstract: High-Volume Anesthesiologist and Surgeon Teams are Associated with Lower Operating Room Charges for Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.

Lymphovascular Invasion in SOUND-Eligible Breast Cancer: Implications for Occult Axillary Nodal Metastasis.

Taking Leave During Breast Surgical Oncology Fellowship: A National Evaluation of Policy and Practice.

The Dual Face of PD-L1 in Perioperative EGFR-Mutated Lung Cancer-Promise, Paradox, and the Path Forward.